ORKA-001 — Topline data
Q3 2026
The Company expects to report Week 28 data from EVERLAST-A for all participants at the end of the third quarter of 2026.Source filing
ORKA biotech catalysts & pipeline
ORUKA THERAPEUTICS INC · Data as of 2026-09-08
Upcoming catalysts
ORKA-001 — Topline data
Dec 2026
The Company also expects to report 52-week data from EVERLAST-A for all participants in December 2026.Source filing
ORKA-001 — Topline data
2027
The Company also continues to advance the Phase 2b EVERLAST-B trial, with data expected in 2027.Source filing
ORKA-002 — Topline data
Q1 2027
The Company now expects to report Week 16 data from ORCA-SURGE, a Phase 2 trial in moderate-to-severe PsO, in the first quarter of 2027.Source filing